OTV is a digital health fund backed by a family platform with Latin American pharma heritage, where partners built and exited seven companies generating over $4 billion in gains before launching the fund—an unusually high level of founder/operator exit experience for a specialist health VC. The fund operates across three continents (Tel Aviv, New York, and Shanghai) to bridge Western innovation with opportunities in North America, Israel, and Asia, concentrating capital in roughly a dozen mid-growth digital health companies rather than running a broad portfolio of many small seed checks.